Market Price

7.10 

-0.02 -0.3%

as of May 24 '19

52 Week Range:

5.45 9.27


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services. This segment supports healthcare professionals and patients at various stages of the product life cycle; and provides field and contact center sales teams, healthcare communications, patient support, audit, advisory, medical information, and event management services to approximately 300 healthcare companies. The Sharp segment provides contract and clinical trial packaging services for the pharmaceutical and biotechnology industries; and serialization solutions. The company was formerly known as United Drug plc and changed its name to UDG Healthcare plc in August 2013. UDG Healthcare plc was founded in 1948 and is based in Dublin, the Republic of Ireland.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Sep '08 Sep '09 Sep '10 Sep '11 Sep '12 Sep '13 Sep '14 Sep '15 Sep '16 Sep '17 Sep '18
Equity (BVPS) 1.17
1.25
1.32
1.38
1.35
1.34
1.45
1.70
2.07
2.39
2.69
growth rate 6.8% 5.6% 4.6% -2.2% -0.7% 8.2% 17.2% 21.8% 15.5% 12.6%
Earnings BIT 45.72
30.57
42.51
34.48
46.06
72.10
54.34
80.84
98.98
106.61
115.77
growth rate -33.1% 39.1% -18.9% 33.6% 56.5% -24.6% 48.8% 22.5% 7.7% 8.6%
Avg.PE 22.17
17.79
15.50
15.20
15.13
32.57
6.52
23.00
23.59
29.44
408.33
growth rate -19.8% -12.9% -1.9% -0.5% 115.3% -80.0% 252.8% 2.6% 24.8% 1,287.0%
ROA 5.79
3.69
4.65
3.82
4.41
2.37
7.88
3.41
13.54
4.91
0.25
growth rate -36.3% 26.0% -17.9% 15.5% -46.3% 232.5% -56.7% 297.1% -63.7% -94.9%
ROE 14.78
10.20
12.49
9.72
11.49
6.85
22.53
9.06
28.99
8.50
0.43
growth rate -31.0% 22.5% -22.2% 18.2% -40.4% 228.9% -59.8% 220.0% -70.7% -94.9%
ROIC 11.08
7.33
8.18
7.04
8.02
5.02
13.64
6.17
19.73
7.10
0.91
growth rate -33.8% 11.6% -13.9% 13.9% -37.4% 171.7% -54.8% 219.8% -64.0% -87.2%
Cur. Ratio 1.66
1.74
1.78
1.86
1.50
1.58
1.69
1.85
2.48
1.99
2.01
growth rate 4.8% 2.3% 4.5% -19.4% 5.3% 7.0% 9.5% 34.1% -19.8% 1.0%
Quick Ratio 1.14
1.13
1.27
1.32
1.04
1.17
1.21
0.74
2.08
1.71
1.79
growth rate -0.9% 12.4% 3.9% -21.2% 12.5% 3.4% -38.8% 181.1% -17.8% 4.7%
Leverage 2.75
2.78
2.60
2.48
2.72
3.06
2.69
2.62
1.74
1.73
1.73
growth rate 1.1% -6.5% -4.6% 9.7% 12.5% -12.1% -2.6% -33.6% -0.6% 0.0%
Balance Sheet Sep '08 Sep '09 Sep '10 Sep '11 Sep '12 Sep '13 Sep '14 Sep '15 Sep '16 Sep '17 Sep '18
Acct.Receivable 284.31
244.70
267.00
268.00
331.00
333.38
371.37
167.53
217.88
291.78
319.13
growth rate -13.9% 9.1% 0.4% 23.5% 0.7% 11.4% -54.9% 30.1% 33.9% 9.4%
Acct.Payable 269.00
218.00
246.00
258.95
270.78
52.79
47.28
58.15
39.92
growth rate -19.0% 12.8% 5.3% 4.6% -80.5% -10.4% 23.0% -31.3%
Cur.Assets 564.68
523.41
568.00
546.00
582.00
689.63
737.83
954.53
730.23
554.83
561.81
growth rate -7.3% 8.5% -3.9% 6.6% 18.5% 7.0% 29.4% -23.5% -24.0% 1.3%
Total Assets 948.30
697.10
957.00
944.00
1,165.00
1,284.88
1,436.08
1,594.51
1,400.44
1,519.95
1,527.16
growth rate -26.5% 37.3% -1.4% 23.4% 10.3% 11.8% 11.0% -12.2% 8.5% 0.5%
Cash 85.00
59.11
156.00
108.00
72.00
174.48
157.84
214.08
428.73
187.47
180.10
growth rate -30.5% 163.9% -30.8% -33.3% 142.3% -9.5% 35.6% 100.3% -56.3% -3.9%
Inventory 165.70
169.40
145.00
143.00
159.00
164.16
167.58
55.02
54.94
55.06
31.25
growth rate 2.2% -14.4% -1.4% 11.2% 3.3% 2.1% -67.2% -0.1% 0.2% -43.3%
Cur.Liabilities 339.84
301.08
320.00
294.00
388.00
435.26
434.54
516.04
293.92
278.95
278.82
growth rate -11.4% 6.3% -8.1% 32.0% 12.2% -0.2% 18.8% -43.0% -5.1% -0.1%
Liabilities 604.00
446.15
589.00
564.00
736.00
865.42
902.40
985.74
593.56
639.29
641.81
growth rate -26.1% 32.0% -4.2% 30.5% 17.6% 4.3% 9.2% -39.8% 7.7% 0.4%
LT Debt 217.20
172.40
231.00
231.00
290.00
378.07
404.83
415.82
242.10
244.40
243.41
growth rate -20.6% 34.0% 0.0% 25.5% 30.4% 7.1% 2.7% -41.8% 1.0% -0.4%
Equity 344.20
250.95
287.65
296.70
334.49
327.55
533.70
608.77
806.88
880.55
885.17
growth rate -27.1% 14.6% 3.2% 12.7% -2.1% 62.9% 14.1% 32.5% 9.1% 0.5%
Common Shares 232.00
234.00
239.00
242.00
240.00
241.00
243.00
245.00
247.00
249.00
250.00
growth rate 0.9% 2.1% 1.3% -0.8% 0.4% 0.8% 0.8% 0.8% 0.8% 0.4%
Cash Flow Statement Sep '08 Sep '09 Sep '10 Sep '11 Sep '12 Sep '13 Sep '14 Sep '15 Sep '16 Sep '17 Sep '18
Capital Expenditures 24.10
5.93
11.00
17.00
63.00
39.27
24.25
36.45
31.74
29.47
39.58
growth rate -75.4% 85.4% 54.6% 270.6% -37.7% -38.3% 50.3% -12.9% -7.2% 34.3%
Cash Dividends 11.30
11.40
9.99
13.74
16.24
17.26
23.29
25.15
30.06
31.28
34.71
growth rate 0.9% -12.3% 37.5% 18.2% 6.3% 34.9% 8.0% 19.5% 4.1% 11.0%
Cash From OA 59.20
50.60
84.00
52.00
78.00
77.54
63.69
137.40
74.34
107.78
102.52
growth rate -14.5% 66.0% -38.1% 50.0% -0.6% -17.9% 115.7% -45.9% 45.0% -4.9%
FCF per Share 0.11
0.21
0.26
0.13
0.04
0.14
-0.06
0.12
0.25
0.17
0.20
growth rate 90.9% 23.8% -50.0% -69.2% 250.0% -100.0% 100.0% 108.3% -32.0% 17.7%
Sale Purchase of Stock 2.22
5.12
4.46
3.18
growth rate 131.0% -13.0% -28.8%
FCF 46.00
77.00
100.00
47.00
18.00
33.00
32.00
82.00
32.00
56.00
42.00
growth rate 67.4% 29.9% -53.0% -61.7% 83.3% -3.0% 156.3% -61.0% 75.0% -25.0%
Income Statement Sep '08 Sep '09 Sep '10 Sep '11 Sep '12 Sep '13 Sep '14 Sep '15 Sep '16 Sep '17 Sep '18
Sales 1,683.70
1,341.34
1,726.00
1,746.00
1,830.00
2,033.02
764.23
919.27
1,083.44
1,219.76
1,315.19
growth rate -20.3% 28.7% 1.2% 4.8% 11.1% -62.4% 20.3% 17.9% 12.6% 7.8%
Op.Income 66.22
48.98
45.00
36.00
48.00
72.10
54.34
80.84
98.98
106.61
115.77
growth rate -26.0% -8.1% -20.0% 33.3% 50.2% -24.6% 48.8% 22.5% 7.7% 8.6%
IBT 58.60
30.53
42.48
34.51
46.07
27.25
108.10
53.62
83.54
92.83
8.39
growth rate -47.9% 39.1% -18.8% 33.5% -40.9% 296.7% -50.4% 55.8% 11.1% -91.0%
Net Income 50.20
26.00
45.00
36.00
48.00
27.55
110.38
54.85
218.52
71.86
3.80
growth rate -48.2% 73.1% -20.0% 33.3% -42.6% 300.7% -50.3% 298.4% -67.1% -94.7%
EPS 0.30
0.21
0.25
0.20
0.26
0.15
0.58
0.25
0.88
0.29
0.02
growth rate -30.0% 19.1% -20.0% 30.0% -42.3% 286.7% -56.9% 252.0% -67.1% -93.1%
Gross Profit 259.70
206.83
267.00
276.00
302.00
326.48
267.50
265.19
315.61
347.85
387.31
growth rate -20.4% 29.1% 3.4% 9.4% 8.1% -18.1% -0.9% 19.0% 10.2% 11.3%

Quarterly Statements

Item Name Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Earnings BIT 29.21
26.07
26.07
31.82
31.82
growth rate -10.8% 0.0% 22.1% 0.0%
Balance Sheet Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Acct.Receivable 291.78
325.68
325.68
319.13
319.13
growth rate 11.6% 0.0% -2.0% 0.0%
Acct.Payable 58.15
242.85
242.85
39.92
39.92
growth rate 317.7% 0.0% -83.6% 0.0%
Cur.Assets 554.83
587.98
587.98
561.81
561.81
growth rate 6.0% 0.0% -4.5% 0.0%
Total Assets 1,519.95
1,514.48
1,514.48
1,527.16
1,527.16
growth rate -0.4% 0.0% 0.8% 0.0%
Cash 187.47
208.84
208.84
180.10
180.10
growth rate 11.4% 0.0% -13.8% 0.0%
Inventory 55.06
51.35
51.35
31.25
31.25
growth rate -6.7% 0.0% -39.2% 0.0%
Cur.Liabilities 278.95
294.84
294.84
278.82
278.82
growth rate 5.7% 0.0% -5.4% 0.0%
Liabilities 639.29
638.95
638.95
641.81
641.81
growth rate -0.1% 0.0% 0.5% 0.0%
LT Debt 244.40
257.21
257.21
243.41
243.41
growth rate 5.2% 0.0% -5.4% 0.0%
Equity 880.55
875.34
875.34
885.17
885.17
growth rate -0.6% 0.0% 1.1% 0.0%
Common Shares 14.62
14.64
14.64
14.64
14.64
growth rate 0.1% 0.0% 0.1% 0.0%
Cash Flow Statement Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Capital Expenditures 6.72
7.35
7.35
12.44
12.44
growth rate 9.3% 0.0% 69.4% 0.0%
Cash Dividends 4.45
12.07
12.07
5.28
5.28
growth rate 171.5% 0.0% -56.2% 0.0%
Cash From OA 24.32
32.68
32.68
18.57
18.57
growth rate 34.4% 0.0% -43.2% 0.0%
Sale Purchase of Stock 0.20
0.39
0.39
growth rate 97.2% 0.0%
FCF 17.60
25.34
25.34
6.13
6.13
growth rate 44.0% 0.0% -75.8% 0.0%
Income Statement Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Sales 320.45
337.65
337.65
319.94
319.94
growth rate 5.4% 0.0% -5.3% 0.0%
Op.Income 29.21
26.07
26.07
31.82
31.82
growth rate -10.8% 0.0% 22.1% 0.0%
IBT 25.96
0.87
0.87
3.32
3.32
growth rate -96.6% 0.0% 280.0% 0.0%
Net Income 20.40
0.55
0.55
1.35
1.35
growth rate -97.3% 0.0% 147.9% 0.0%
EPS
growth rate
Gross Profit 90.91
95.22
95.22
98.43
98.43
growth rate 4.7% 0.0% 3.4% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

E (17.08)

YOY Growth Grade:

E (27.40)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 473.33 473.33 13.65
EPS / Growth 4.4% 0.02 14.5%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 12.9%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 4.4% 10.6% 10.6%
Future PE 8.82 17.40 17.40
Future EPS 0.02 0.04 0.04
Value Price
MOS %
0.05
-99.3%
0.18
-97.5%
0.18
-97.5%
MOS Price 0.03 0.09 0.09
IRT 70.53 38.15 38.15

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.